NASDAQ: DBVTDbv Technologies Sa Stock Ownership - Who owns Dbv Technologies Sa?
Insider buying vs selling
Have Dbv Technologies Sa insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Pharis Mohideen | Chief Medical Officer | 2025-01-30 | 600 | $0.85 | $510.00Sell |
| Pharis Mohideen | Chief Medical Officer | 2024-11-25 | 565 | $0.57 | $322.05Sell |
| Pharis Mohideen | Chief Medical Officer | 2024-11-22 | 342 | $0.53 | $181.26Sell |
| Pharis Mohideen | Chief Medical Officer | 2024-11-21 | 2,350 | $0.54 | $1.27kSell |
| Pharis Mohideen | Chief Medical Officer | 2024-07-29 | 1,785 | $0.98 | $1.75kSell |
| Pharis Mohideen | Chief Medical Officer | 2024-05-24 | 660 | $1.36 | $897.60Sell |
| Pharis Mohideen | Chief Medical Officer | 2024-05-22 | 382 | $1.38 | $527.16Sell |
DBVT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when DBVT insiders and whales buy or sell their stock.
DBVT Shareholders
What type of owners hold Dbv Technologies Sa stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Bros Advisors LP | 10.64% | 14,575,984 | $143.28M | Insider |
| Sa Bpifrance | 7.96% | 10,898,595 | $107.13M | Insider |
| Baker Bros Advisors LP | 1.07% | 1,461,425 | $14.37M | Institution |
| Yiheng Capital Management LP | 0.48% | 656,309 | $6.45M | Institution |
| Point72 Asset Management LP | 0.21% | 286,250 | $2.81M | Institution |
| Investissement Sas Bpifrance | 0.17% | 226,133 | $2.22M | Insider |
| Ubs Group Ag | 0.12% | 162,376 | $1.60M | Institution |
| Pharis Mohideen | 0.08% | 110,510 | $1.09M | Insider |
| Boxer Capital Management LLC | 0.04% | 50,000 | $491.50k | Institution |
| Morgan Stanley | 0.03% | 45,721 | $449.44k | Institution |
DBVT vs Biotech Stocks
Dbv Technologies Sa Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.